These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11524467)

  • 1. High-dose estradiol improves cognition for women with AD: results of a randomized study.
    Asthana S; Baker LD; Craft S; Stanczyk FZ; Veith RC; Raskind MA; Plymate SR
    Neurology; 2001 Aug; 57(4):605-12. PubMed ID: 11524467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.
    Asthana S; Craft S; Baker LD; Raskind MA; Birnbaum RS; Lofgreen CP; Veith RC; Plymate SR
    Psychoneuroendocrinology; 1999 Aug; 24(6):657-77. PubMed ID: 10399774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial.
    Wharton W; Baker LD; Gleason CE; Dowling M; Barnet JH; Johnson S; Carlsson C; Craft S; Asthana S
    J Alzheimers Dis; 2011; 26(3):495-505. PubMed ID: 21694454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function in association with sex hormones in postmenopausal women.
    Kocoska-Maras L; Rådestad AF; Carlström K; Bäckström T; von Schoultz B; Hirschberg AL
    Gynecol Endocrinol; 2013 Jan; 29(1):59-62. PubMed ID: 22967437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive response to estradiol in postmenopausal women is modified by high cortisol.
    Baker LD; Asthana S; Cholerton BA; Wilkinson CW; Plymate SR; Green PS; Merriam GR; Fishel MA; Watson GS; Cherrier MM; Kletke ML; Mehta PD; Craft S
    Neurobiol Aging; 2012 Apr; 33(4):829.e9-20. PubMed ID: 21855173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.
    Yaffe K; Vittinghoff E; Ensrud KE; Johnson KC; Diem S; Hanes V; Grady D
    Arch Neurol; 2006 Jul; 63(7):945-50. PubMed ID: 16831962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study.
    Baker LD; Sambamurti K; Craft S; Cherrier M; Raskind MA; Stanczyk FZ; Plymate SR; Asthana S
    Am J Geriatr Psychiatry; 2003; 11(2):239-44. PubMed ID: 12611754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men.
    Cherrier MM; Plymate S; Mohan S; Asthana S; Matsumoto AM; Bremner W; Peskind E; Raskind M; Latendresse S; Haley AP; Craft S
    Psychoneuroendocrinology; 2004 Jan; 29(1):65-82. PubMed ID: 14575730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women.
    Dunkin J; Rasgon N; Wagner-Steh K; David S; Altshuler L; Rapkin A
    Psychoneuroendocrinology; 2005 Apr; 30(3):284-96. PubMed ID: 15511602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
    Shah S; Bell RJ; Savage G; Goldstat R; Papalia MA; Kulkarni J; Donath S; Davis SR
    Menopause; 2006; 13(4):600-8. PubMed ID: 16837882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
    Joffe H; Hall JE; Gruber S; Sarmiento IA; Cohen LS; Yurgelun-Todd D; Martin KA
    Menopause; 2006; 13(3):411-22. PubMed ID: 16735938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.
    Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Khaylis A; Rasgon NL
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):792-802. PubMed ID: 21873835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.
    Valen-Sendstad A; Engedal K; Stray-Pedersen B; ; Strobel C; Barnett L; Meyer N; Nurminemi M
    Am J Geriatr Psychiatry; 2010 Jan; 18(1):11-20. PubMed ID: 20094015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of estradiol administration mode on plasma insulin-like growth factor-I (IGF-I) and its binding proteins 1 and 3 concentration in postmenopausal women treated with norethisterone acetate].
    Milewicz T; Krzysiek J; Rogatko I; Sztefko K; Stochmal E; Hubalewska-Dydejczyk A; Jach R; Radowicki S
    Ginekol Pol; 2011 Mar; 82(3):200-4. PubMed ID: 21735688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY; Leung KC; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 2000 May; 85(5):1918-22. PubMed ID: 10843175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females.
    Duka T; Tasker R; McGowan JF
    Psychopharmacology (Berl); 2000 Apr; 149(2):129-39. PubMed ID: 10805607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF; Harman SM; Cho DE; Blackman MR
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
    Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.